Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mechano-Therapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Mechano-Therapeutics

Mechano-Therapeutics

Pre-Seed

Philadelphia-based medical firm specializing in advanced drug delivery systems for enhanced therapy.

HQ
Philadelphia, PA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Mechano-Therapeutics, founded as a spin-out from the University of Pennsylvania, is a Philadelphia-based medical firm dedicated to revolutionizing musculoskeletal health through advanced drug delivery systems. The company’s core mission is to enhance therapeutic performance using innovative microcapsule technology. Their primary focus is on developing and commercializing these cutting-edge drug delivery solutions to improve patient outcomes in the musculoskeletal health market.

Notable affiliated individuals include researchers and experts from the University of Pennsylvania, contributing to the company's strong scientific foundation. Mechano-Therapeutics has garnered attention from investors interested in pioneering medical technologies. Key achievements include successful preclinical trials demonstrating the efficacy of their microcapsule drug delivery systems. The company’s impact lies in its potential to significantly improve treatment protocols and patient care in musculoskeletal health.

Mechano-Therapeutics - Similar Companies

Mekanistic Therapeutics logo

Mekanistic Therapeutics

mekanistic.com

Enable Therapeutics logo

Enable Therapeutics

Myotherix logo

Myotherix

Therapyx logo

Therapyx

therapyxinc.com

Amplicore logo

Amplicore

Neurocarrus logo

Neurocarrus

neurocarrus.com

Interius BioTherapeutics logo

Interius BioTherapeutics

interiusbio.com

Controlled Delivery Systems logo

Controlled Delivery Systems

Theracos logo

Theracos

theracos.com

Micron Biomedical logo

Micron Biomedical

SpringLeaf Therapeutics logo

SpringLeaf Therapeutics

BlueWhale Bio logo

BlueWhale Bio

bluewhale.bio

Edulis Therapeutics logo

Edulis Therapeutics

edulis.xyz

Talima Therapeutics logo

Talima Therapeutics

talima.com

BioInteractive Technologies logo

BioInteractive Technologies

Mechano-Therapeutics - Quick Facts

Who are Mechano-Therapeutics' competitors?

Companies similar to Mechano-Therapeutics include Mekanistic Therapeutics, Enable Therapeutics, Myotherix and Therapyx.

When was Mechano-Therapeutics founded?

Mechano-Therapeutics was founded in 2021.

Where is Mechano-Therapeutics' headquarters located?

Mechano-Therapeutics' headquarters is located in Philadelphia, PA, US.

When was Mechano-Therapeutics' last funding round?

Mechano-Therapeutics' most recent funding round was for $800k (USD) in June 2023.

How much has Mechano-Therapeutics raised to-date?

As of Jun 1, 2023, Mechano-Therapeutics has raised a total of $800k (USD).

How many employees does Mechano-Therapeutics have?

Mechano-Therapeutics has 9 employees as of Feb 4, 2024.

Mechano-Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Enterprise
Revenue
  • Recurring
  • Software
Main Product
  • Drug Delivery
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research